- Sembcorp's share price weakness is overdone in our view, offering an attractive entry for patient, yield-focused investors. Maintain BUY.
Stable earnings for 1H25.
- - Read this at SGinvestors.io -
- The company’s S$0.09/share dividend declared for 1H25 was 50% higher than 1H24’s S$0.06. See Sembcorp's dividend payout date.
Overreaction presents a buying opportunity.
- In our view, the 14% decline of Sembcorp's share price on 8 August, wiping out nearly S$2b in market cap, was an overreaction and presents a buying opportunity for the patient investor.
- - Read this at SGinvestors.io -
Strong balance sheet.
- Read more at SGinvestors.io.